Gary Ingenito, Chief Med. & Reg. Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 50,000 shares at $14.02 ($701K) on 2023-12-06, disclosed to the SEC on 2023-12-08.
Seasonal sale ($701k) by Chief Med. & Reg. Officer — this insider has traded CPRX in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CPRX | SELL | 2024-11-29 | $545K | — | Filing → |
| CPRX | SELL | 2024-11-22 | $806K | — | Filing → |
| CPRX | SELL | 2024-08-13 | $1.8M | — | Filing → |